← Open Payments lookup

MELISSA AMANN: Open Payments

NPI 1275886012 · SAINT LOUIS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$222 in 12 payments from 11 companies in 2025. Trend: 2023 $792 · 2024 $667 · 2025 $222

Food & beverage: $222
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP2$46
Sumitomo Pharma America, Inc.1$29
Boehringer Ingelheim Pharmaceuticals, Inc.1$22
PFIZER INC.1$19
Averitas Pharma Inc.1$18
Abbott Laboratories1$16
Amgen Inc.1$15
Verona Pharma, Inc.1$15
GlaxoSmithKline, LLC.1$15
Electromed, Inc.1$14

Products named: GEMTESA, FARXIGA, JARDIANCE, BREZTRI, PREVNAR 20, QUTENZA, FREESTYLE LIBRE 3, OTEZLA.

Industry payments across MO — which companies pay providers there.